UBS Group Boosts Travelers Companies (NYSE:TRV) Price Target to $244.00

Travelers Companies (NYSE:TRVGet Free Report) had its price target boosted by analysts at UBS Group from $238.00 to $244.00 in a report released on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the insurance provider’s stock. UBS Group’s price target suggests a potential upside of 0.92% from the company’s current price.

Other equities research analysts have also issued reports about the company. Wells Fargo & Company raised their price objective on Travelers Companies from $206.00 to $207.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Morgan Stanley lowered their price target on Travelers Companies from $220.00 to $210.00 and set an “equal weight” rating for the company in a research report on Friday, July 19th. Bank of America boosted their price objective on shares of Travelers Companies from $223.00 to $241.00 and gave the company an “underperform” rating in a research report on Thursday, October 10th. Citigroup raised their target price on shares of Travelers Companies from $200.00 to $203.00 and gave the stock a “sell” rating in a report on Tuesday, July 30th. Finally, William Blair reaffirmed a “market perform” rating on shares of Travelers Companies in a research note on Friday, June 28th. Four research analysts have rated the stock with a sell rating, fourteen have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Travelers Companies currently has a consensus rating of “Hold” and a consensus target price of $231.63.

View Our Latest Stock Analysis on TRV

Travelers Companies Price Performance

TRV traded up $1.65 during trading hours on Tuesday, hitting $241.77. The company’s stock had a trading volume of 269,226 shares, compared to its average volume of 1,305,507. The stock has a market cap of $55.11 billion, a price-to-earnings ratio of 15.25, a P/E/G ratio of 1.23 and a beta of 0.62. The business’s 50-day moving average price is $228.43 and its 200-day moving average price is $218.82. The company has a current ratio of 0.33, a quick ratio of 0.33 and a debt-to-equity ratio of 0.32. Travelers Companies has a 12 month low of $157.33 and a 12 month high of $243.48.

Travelers Companies (NYSE:TRVGet Free Report) last issued its quarterly earnings data on Friday, July 19th. The insurance provider reported $2.51 EPS for the quarter, missing analysts’ consensus estimates of $3.23 by ($0.72). The business had revenue of $11.28 billion during the quarter, compared to analysts’ expectations of $11.35 billion. Travelers Companies had a return on equity of 15.90% and a net margin of 8.37%. The business’s quarterly revenue was up 11.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.06 earnings per share. Sell-side analysts expect that Travelers Companies will post 17.08 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Travelers Companies news, EVP Michael Frederick Klein sold 10,000 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $211.44, for a total transaction of $2,114,400.00. Following the sale, the executive vice president now owns 22,798 shares of the company’s stock, valued at approximately $4,820,409.12. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.33% of the stock is currently owned by insiders.

Institutional Trading of Travelers Companies

Hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. lifted its position in Travelers Companies by 36.8% during the first quarter. JPMorgan Chase & Co. now owns 11,743,236 shares of the insurance provider’s stock valued at $2,702,588,000 after acquiring an additional 3,158,979 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Travelers Companies by 5.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,044,839 shares of the insurance provider’s stock valued at $619,241,000 after purchasing an additional 165,708 shares during the last quarter. Legal & General Group Plc grew its stake in Travelers Companies by 1.6% during the 2nd quarter. Legal & General Group Plc now owns 2,334,882 shares of the insurance provider’s stock worth $474,774,000 after buying an additional 37,029 shares during the last quarter. Boston Partners increased its position in Travelers Companies by 16.4% during the 1st quarter. Boston Partners now owns 1,388,019 shares of the insurance provider’s stock valued at $319,348,000 after buying an additional 196,011 shares in the last quarter. Finally, AQR Capital Management LLC raised its stake in Travelers Companies by 8.0% in the second quarter. AQR Capital Management LLC now owns 1,150,213 shares of the insurance provider’s stock valued at $233,769,000 after buying an additional 85,619 shares during the last quarter. 82.45% of the stock is owned by hedge funds and other institutional investors.

Travelers Companies Company Profile

(Get Free Report)

The Travelers Companies, Inc, through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United States and internationally. The company operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance.

Further Reading

Analyst Recommendations for Travelers Companies (NYSE:TRV)

Receive News & Ratings for Travelers Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Travelers Companies and related companies with MarketBeat.com's FREE daily email newsletter.